Stockreport

Cellect Announces Positive Clinical Results

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF - One-month assessment of half of the planned patients in the ApoGraft™ study show complete engraftment and zero related adverse events - First cohort of patients comple [Read more]